Share on StockTwits

Compugen (NASDAQ:CGEN) posted its quarterly earnings results on Monday. The company reported ($0.04) earnings per share (EPS) for the quarter, American Banking & Market News reports. The company had revenue of $2.10 million for the quarter.

Shares of Compugen (NASDAQ:CGEN) opened at 7.95 on Monday. Compugen has a one year low of $5.04 and a one year high of $14.32. The stock has a 50-day moving average of $9.47 and a 200-day moving average of $10.15. The company’s market cap is $329.2 million.

On a related note, analysts at Jefferies Group initiated coverage on shares of Compugen in a research note on Wednesday, March 19th. They set a “buy” rating and a $17.00 price target on the stock.

Compugen Ltd. (NASDAQ:CGEN) is an early-stage drug and diagnostic discovery company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.